Trial Outcomes & Findings for Alternative Approaches for Nausea Control (NCT NCT01695993)

NCT ID: NCT01695993

Last Updated: 2018-06-26

Results Overview

Nausea and will be measured by a patient report diary completed by patients over a five-day period. Each day is divided into four segments (morning, afternoon, evening, night) in which patients report the severity of nausea and number of vomiting episodes for each period of the day. Severity of nausea is assessed on a 7-point rating scale, anchored at one end by 1 = "Not at all nauseated" and at the other end by 7 = "Extremely nauseated." The outcome variable for the primary analysis was greatest reported nausea from the five day period.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

242 participants

Primary outcome timeframe

five days

Results posted on

2018-06-26

Participant Flow

Participant milestones

Participant milestones
Measure
Arm 1
Patients receive standard care only
Arm 2
Handout without expectancy- enhancing component Relaxation MP3 without expectancy-enhancing component \- Acupressure bands
Arm 3
Handout with expectancy- enhancing component Relaxation MP3 with expectancy- enhancing component Acupressure bands
Overall Study
STARTED
81
80
81
Overall Study
COMPLETED
76
75
75
Overall Study
NOT COMPLETED
5
5
6

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm 1
Patients receive standard care only
Arm 2
Handout without expectancy- enhancing component Relaxation MP3 without expectancy-enhancing component \- Acupressure bands
Arm 3
Handout with expectancy- enhancing component Relaxation MP3 with expectancy- enhancing component Acupressure bands
Overall Study
Lost to Follow-up
2
1
3
Overall Study
Withdrawal by Subject
2
2
2
Overall Study
To ill to continue
1
2
0
Overall Study
Changed Medical Facility
0
0
1

Baseline Characteristics

Alternative Approaches for Nausea Control

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm 1
n=76 Participants
Patients will receive only standard care
Arm 2
n=75 Participants
* Handout without expectancy- enhancing component * Relaxation MP3 without expectancy-enhancing component * Acupressure bands
Arm 3
n=75 Participants
* Handout with expectancy- enhancing component * Relaxation MP3 with expectancy-enhancing component * Acupressure bands
Total
n=226 Participants
Total of all reporting groups
Age, Continuous
53.2 years
STANDARD_DEVIATION 11.5 • n=5 Participants
53.2 years
STANDARD_DEVIATION 11.6 • n=7 Participants
52.6 years
STANDARD_DEVIATION 10.5 • n=5 Participants
53 years
STANDARD_DEVIATION 11.2 • n=4 Participants
Sex: Female, Male
Female
76 Participants
n=5 Participants
75 Participants
n=7 Participants
75 Participants
n=5 Participants
226 Participants
n=4 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
5 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
73 Participants
n=5 Participants
74 Participants
n=7 Participants
73 Participants
n=5 Participants
220 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
4 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
7 Participants
n=5 Participants
6 Participants
n=7 Participants
6 Participants
n=5 Participants
19 Participants
n=4 Participants
Race (NIH/OMB)
White
67 Participants
n=5 Participants
66 Participants
n=7 Participants
66 Participants
n=5 Participants
199 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
2 Participants
n=4 Participants
Region of Enrollment
United States
76 participants
n=5 Participants
75 participants
n=7 Participants
75 participants
n=5 Participants
226 participants
n=4 Participants

PRIMARY outcome

Timeframe: five days

Nausea and will be measured by a patient report diary completed by patients over a five-day period. Each day is divided into four segments (morning, afternoon, evening, night) in which patients report the severity of nausea and number of vomiting episodes for each period of the day. Severity of nausea is assessed on a 7-point rating scale, anchored at one end by 1 = "Not at all nauseated" and at the other end by 7 = "Extremely nauseated." The outcome variable for the primary analysis was greatest reported nausea from the five day period.

Outcome measures

Outcome measures
Measure
Standard Care
n=76 Participants
Patients receive only standard care
Expectancy-Neutral Condition
n=75 Participants
* Handout without expectancy- enhancing component * Relaxation MP3 without expectancy-enhancing component * Acupressure bands
Expectancy-Enhancing Condition
n=75 Participants
* Handout with expectancy-enhancing component * Relaxation MP3 with expectancy-enhancing component * Acupressure bands
Patient Report Nausea Diary
3.87 units on a scale
Standard Deviation 2.00
3.55 units on a scale
Standard Deviation 2.00
3.52 units on a scale
Standard Deviation 1.73

Adverse Events

Arm 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 3

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Joseph A. Roscoe, PhD Associate Research Professor

University of Rochester Medical Center

Phone: 585 275-9962

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place